• Reports

      Reports

      Stay ahead and make informed decisions with Delvens insightful analysis on key business and technological trends.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Best Practice Guide

      Best Practice Guides

      The Delvens Best Practice Team offers practical tactics, procedures, and resources to help you address the major growth-related dos and don'ts.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Expertise

      Expertise

      Delvens' decades of experience helps you to strategize, plan, optimize and win.

      See What we can do
      • Syndicated Research
      • Custom Research
      • Consulting
      • Implementation Support
      • Audio-Video Infographic Workshops
      • Subscription Model
      • Bundle Reports Model
      • Best Practice Guides
  • Innovation

      Innovation

      Gain thought-provoking insights on some of the biggest trends in the world to guide you in the phase of innovation.

      Let's Innovate

      Latest Chronicles

      CMOs

      What Will Matter To CMOs In 2023?

      11th March 2023

      Featured Chronicle

      Environment Society Governance

      Why ESG is more important than ever!

      4th November 2022
  • Innovation
  • Explore

      Explore

      From accelerating growth and providing strategic vision to the world's biggest brands, to lunch-break sneaker shopping on Melrose, and thirsty Thursdays at the local pubs. We have a Hustling atmosphere because growing together should be fun, or why do it?

      Let's Explore Something

      About

      • Who We Are
      • Why Choose Us
      • Research Methodology
      • Careers
      • Contact

      Help

      • Customer FAQs
      • How To Order
      • Delivery Method
      • Return Policy
      • Privacy Policy
      • Terms of Use
  • Newscast

      Blogs

      Digital Future of Europe

      Shaping the Digital Future of Europe

      10th March 2023
      Let's Read

      Press Room

      Telemedicine

      Telemedicine – For the Future

      11th March 2023
      Let's Understand

      Article

      Enterprise Resource Planning (ERP) Market

      16th March 2023
      Let's Study
  • Newscast
      • Blog
      • Article
      • Pressroom
Healthcare Icon

Neurovascular Devices Market - Trends Forecast Till 2030

Neurovascular Devices Market Size, Share & Trends Analysis Report, By Device (Cerebral Embolization & Aneurysm Coiling Devices), By Therapeutic Application (Stroke, Cerebral Artery Stenosis), and region (North America, Europe, Asia-Pacific, Middle East, and Africa and South America).

  • Published Date : January 2023
  • Base Year Estimate : 2022
  • Report ID : D-HC-NDM-1286
  • Format :
  • Number of Pages : 638
  • Domain : Healthcare
  1. Healthcare
  2. Neurovascular Devices Market - Trends Forecast Till 2030
Buy Now Get Free Sample Now
REPORT SYNOPSIS
Market Snapshot Market Overview Delvens Industry Expert's Standpoint Market Portfolio Key Findings Regional Analysis Competitive Landscape Recent Developments Reasons to Acquire Report Scope
Table Of Content Frequently Asked Questions

Market Snapshot

Market Overview

The global Neurovascular Devices Market size is 2.84 billion USD in 2022 and is projected to reach a CAGR of 6.0% from 2023-2030.

Vascular disorders of the brain and central nervous system are diagnosed and treated with the aid of interventional neurology devices. Angiography, fluoroscopy, endovascular procedures, and catheter-based techniques are all included in interventional neurology. One of the earliest primary in-vivo brain vascular imaging techniques, catheter angiography is used to diagnose a number of neurological diseases, including cerebral aneurysm, arteriovenous malformations, intracranial stenosis, arteriovenous fistula, and vasculitis.

The market is anticipated to be driven by the rising frequency of neurological illnesses, technological developments, and rising demand for less invasive procedures. The increase in R&D investments in the biotechnology and pharmaceutical industry will also be the major driving factor of the neurovascular devices market. An expanding patient population for ischemic and hemorrhagic stroke as well as a rise in demand for minimally invasive treatments for neurovascular disease may be to blame for the market's expansion.

The market is anticipated to be moderately and temporarily affected by COVID-19. Depending on the state of the local health systems and the steps taken to battle the pandemic, the effect of the epidemic on the market differs by country. The epidemic has had a negative effect on neuro care and neurosurgeons. Brain procedures have frequently been delayed or even canceled during this time in order to stop the coronavirus from spreading.

Neurosurgical operations decreased by 55% in the worst-affected countries, including the United States, Russia, India, Brazil, France, the United Kingdom, Italy, and Spain. However, up to 36% of hospitalized COVID-19 patients may experience neurological symptoms, and there have been several cases of ischemic and hemorrhagic infarction.

In a nutshell, the delay in elective surgeries caused by Covid-19 had a substantial impact on the market for neurovascular devices. The neurovascular devices sector is also harmed by cases of brain aneurysms that go undiagnosed and unreported. The usage of minimally invasive procedures and the support of R&D in this field are being driven by reduced postoperative discomfort and quicker recovery. Additionally, those who contracted the Covid-19 infection later exhibited neurological illness symptoms, which are most likely to foster market growth.

Delvens Industry Expert's Standpoint

The adoption of neurovascular devices among medical professionals and patients will continue to expand as a result of the rise in demand for minimally invasive surgical procedures and post-surgery techniques such as shorter hospital stays, affordability, and quicker patient recovery. The variety of neurovascular instruments available for treating various aneurysm types with higher safety and effectiveness will continue to grow thanks to novel technologies, and aneurysm management is always evolving with cutting-edge technology at the forefront of innovation.

 

Market Portfolio

Key Findings

  • The cerebral angioplasty and stenting systems, cerebral embolization and aneurysm coiling devices, and support devices categories make up the neurovascular device market. Flow diversion devices, embolic coils, and liquid embolic agents are further divided into the category of cerebral embolization and aneurysm coiling devices. Embolic protection systems and carotid artery stents are further subcategories of cerebral angioplasty and stenting systems. Devices used in neuro thrombectomy are further divided into clot retrieval, suction, and vascular snare categories. Due to the rising incidence of acute ischemic stroke and the rising number of product launches by the major market players, the segment for neuro-thrombectomy devices is anticipated to develop at the greatest CAGR during the forecast period.
     
  • The therapeutic application segment is further segmented into the stroke, cerebral aneurysms, and others. Given the rising prevalence of stroke, hypertension, and other neurological illnesses in 2021, the stroke sector dominated the market with a CAGR of 6.2%. During the forecast period, the cerebral aneurysm segment is anticipated to increase at the highest CAGR primarily due to the rising incidence of intracranial aneurysms.

 

Regional Analysis

Asia Pacific to Dominate the Market

  • Due to the presence of major producers in the North American region, including Stryker Corporation, Penumbra, Inc., Johnson & Johnson, and Merit Medical Systems, Inc., North America held the largest market share and dominated the market in 2021.
     
  • Due to factors including the increasing prevalence of target diseases, Asia Pacific is anticipated to expand at the greatest CAGR during the projection period.

 

Competitive Landscape

  • Medtronic
  • Johnson and Johnson Services Inc.
  • Penumbra, Inc.
  • Microport Scientific Corporation
  • Stryker
  • Microvention Inc (Terumo Corporation)
  • Codman Neuro (Integra Lifesciences)